Strategies for In Vitro Metabolic Stability Testing ...
2 Presentation Overview • Overview of in vitro metabolic stability testing • In vitro model systems and assay conditions • In vitro / in vivo Extrapolations
Download - Wed, 29 Oct 2014 23:28:00 GMT
Essential IND Strategies: Fundamental Considerations on ...
Drug Development….Highly Integrated Process In Vitro ADME • Log D, Solubility • Cytotoxicity • Protein binding • Permeability • Metabolism
Download - Wed, 29 Oct 2014 01:38:00 GMT
Why, When, and How to Conduct 14C Human Studies
lifE SCiEnCE i TECHniCAl bUllETin 2 This article aims at presenting diverse strategies supporting the management of the risk related to drug metabolites,
Download - Tue, 28 Oct 2014 02:36:00 GMT
Download - Harlan Laboratories - Animal Research ...
3 General Toxicology Harlan Laboratories performs a full range of toxicology studies to support the pharmaceutical, chemical, and agrochemical industries.
Download - Mon, 27 Oct 2014 17:18:00 GMT
High Throughput CYP Inhibition Assays Using RapidFire ...
Presentation overview • Why conduct cytochrome P450 inhibition testing? • Strategies for high throughput screening • Advantages of BD Gentest assays coupled with
Download - Tue, 28 Oct 2014 23:57:00 GMT
Drugs against parasitic diseases: R&D methodologies and issues
Drugs against parasitic diseases: R&D methodologies and issues Discoveries and drug development UNDP/World Bank/WHO Special Programme for Research and
Download - Tue, 28 Oct 2014 21:34:00 GMT
Overall Drug Discovery and Development Process
• High quality Leads are derived from high quality hits. • The key to finding high quality hits depends on a successful match of lead generation strategies and ...
Download - Wed, 29 Oct 2014 14:52:00 GMT
Biopharmaceutical Classification System and Formulation ...
©2011 Particle Sciences, Inc. All rights reserved. Biopharmaceutical Classification System and Formulation Development Technical Brief 2011 Volume 9
Download - Tue, 28 Oct 2014 21:56:00 GMT
CENTER FOR DRUG EVALUATION AND RESEARCH
center for drug evaluation and research application number: 22-264 medical review(s)
Download - Wed, 29 Oct 2014 02:06:00 GMT